Company Valuation: MEDICLIN AG

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 186.2 171 130.2 115 175.8 202.4 - -
Change - -8.16% -23.89% -11.68% 52.89% 15.14% - -
Enterprise Value (EV) 186.2 171 130.2 115 175.8 202.4 202.4 202.4
Change - -8.16% -23.89% -11.68% 52.89% 15.14% 0% 0%
P/E - - - - - - - -
PBR 1.02x 0.82x 0.66x 0.52x 0.71x 0.71x 0.63x 0.56x
PEG - - - - - - - -
Capitalization / Revenue 0.28x 0.24x 0.18x 0.15x 0.22x 0.26x 0.25x 0.25x
EV / Revenue 0x 0x 0x 0x 0x 0.26x 0.25x 0.25x
EV / EBITDA 0x 0x 0x 0x 0x 1.77x 1.76x 1.75x
EV / EBIT 0x 0x 0x 0x 0x 3.26x 3.24x 3.23x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - 0.04 0.04 0.04 0.04
Rate of return - - - - 1.08% 0.94% 0.94% 0.94%
EPS 2 - - - - - - - -
Distribution rate - - - - - - - -
Net sales 1 673.1 704.7 730.1 748.8 784.5 787.5 803.2 819.3
EBITDA 1 85.22 90.92 98.73 103.8 115.6 114.3 115.3 115.6
EBIT 1 11.56 19.52 12.72 53.49 55.36 62.11 62.47 62.72
Net income 1 1.461 9.441 -10.78 24.84 25.49 36.66 38.2 40.12
Net Debt - - - - - - - -
Reference price 2 3.920 3.600 2.740 2.420 3.700 4.260 4.260 4.260
Nbr of stocks (in thousands) 47,500 47,500 47,500 47,500 47,500 47,500 - -
Announcement Date 3/30/22 3/31/23 3/27/24 3/28/25 3/27/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - 0.94% 230M
32.02x3.06x13.78x1.36% 17.93B
66.41x5.23x35.43x0.27% 13.15B
21.22x3.02x10.78x1.99% 11.58B
18.33x2.12x9.95x0.68% 11.2B
24.45x1.96x16.33x0.15% 10.03B
18.53x2.7x11.11x4.31% 8.92B
52.3x6.92x28.86x0.12% 7.44B
32.29x0.88x7.33x2% 6.8B
12.33x1.08x7.1x2.11% 6.69B
Average 30.88x 3.00x 15.63x 1.39% 9.4B
Weighted average by Cap. 32.00x 3.10x 16.26x 1.36%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. MED Stock
  4. Valuation MEDICLIN AG